POPULARITY
Over the last century Americans have experienced extreme changes in how we go about our daily lives. Many of these modern conveniences are contributing to chronic diseases and poor mental health. Why are young people at a higher risk of depression than their grandparents? And what can we do to improve our physical and mental health. If you are in a crisis or think you have an emergency, call your doctor or 911. If you're considering suicide, call 1-800-273-TALK to speak with a skilled trained counselor.RADICALLY GENUINE PODCASTRadically Genuine Podcast Website Twitter: Roger K. McFillin, Psy.D., ABPPInstagram @radgenpodTikTok @radgenpodRadGenPodcast@gmail.comADDITIONAL RESOURCESDepression as a disease of modernity: explanations for increasing prevalence - PMC3:30 - The serotonin theory of depression: a systematic umbrella review of the evidence | Molecular Psychiatry5:00 - Birth cohort increases in psychopathology among young Americans, 1938–2007: A cross-temporal meta-analysis of the MMPI - ScienceDirect14:30 - Christopher Palmer, MD - Brain Energy: A Revolutionary Breakthrough in Understanding Mental Health--and Improving Treatment for Anxiety, Depression, OCD, PTSD, and More17:00 - Austin Powers: The Spy Who Shagged Me (1999) - Quotes - IMDb25:00 - Sleep in America® Polls28:00 - Radically Genuine Podcast | 10. How to improve your sleep
The overwhelming consumer demand that was misunderstood by manufacturers will soon cause gluts in everything. https://learningenglish.voanews.com/a... uneducatedeconomist.com uneducatedeconomist@gmail.com real mail P.O. 731 Astoria, OR 97103 Instagram uneducated.economist Patreon https://www.patreon.com/UneducatedEco... Want to buy me a coffee? https://www.paypal.me/meatbingo https://cash.app/$bingo503 https://venmo.com/code?user_id=211351... --- Support this podcast: https://anchor.fm/youguysletmeknow/support
Critical psychiatrist joins us to explore the history and development of psychiatric medication, why there is little, if any, evidence to support the idea that psychiatric medication is correcting a “chemical imbalance” or any other underlying cause of mental illness, why the disease-centred model of mental health issues is both misleading and disempowering to service users, and ultimately, why much of the “science” supporting psychiatric medication is based more on ideology than evidence. *** PATREON *** https://patreon.com/myownworstenemy *** BOOKS MENTIONED *** "The Myth of the Chemical Cure" by Joanna Moncrieff https://amzn.to/2MxG5po "A Straight Talking Guide to Psychiatric Drugs" by Joanna Moncrieff https://amzn.to/2nlq6j9 "The Bitterest Pills" by Joanna Moncrieff https://amzn.to/2vwpgob "A Woman in Berlin" by Anonymous https://amzn.to/2Miosgc "Das Kapital (Capital Vol. 1)" by Karl Marx https://amzn.to/2KL9cnv "Manufacturing Depression" by Gary Greenberg https://amzn.to/2MiOTCt "Crazy Like Us" by Ethan Watters https://amzn.to/2MBZLZ6 *** SOCIAL MEDIA *** Facebook: http://facebook.com/myownworstenemyorg Twitter: http://twitter.com/dannydwhittaker *** CREDITS *** Theme Music: Falling Down by Ryan Little http://youtube.com/user/TheR4C2010 Podcast Image: IGypsyWoman https://flic.kr/p/NtCRK3 DISCLAIMER: My Own Worst Enemy is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk and affiliated sites.
Why did the fifth edition of the Diagnostic and Statistic Manual become so controversial? Is it possible to alleviate human suffering without classifying it as a mental disorder? Gary Greenberg, psychotherapist, author of Manufacturing Depression and The Book of Woe: The DSM and the Unmaking of Psychiatry, and journalist for Harper’s, the New Yorker, and […]
Gary Greenberg, psychologist and author of The Noble Lie and Manufacturing Depression, talks with EconTalk host Russ Roberts about the nature of addiction, depression and mental illness. Drawing on ideas in the two books, Greenberg argues that there are strong monetary incentives to define various problems as illnesses that psychiatrists "cure" with drugs. Greenberg argues that this distorts science and has strong impacts, good and bad, on how we view ourselves and the challenges of life. The conversation looks at the scientific basis for addiction and the role brain chemistry in depression. The conversation closes with a discussion of Greenberg's correspondence with the Unabomber.
Gary Greenberg, psychologist and author of The Noble Lie and Manufacturing Depression, talks with EconTalk host Russ Roberts about the nature of addiction, depression and mental illness. Drawing on ideas in the two books, Greenberg argues that there are strong monetary incentives to define various problems as illnesses that psychiatrists "cure" with drugs. Greenberg argues that this distorts science and has strong impacts, good and bad, on how we view ourselves and the challenges of life. The conversation looks at the scientific basis for addiction and the role brain chemistry in depression. The conversation closes with a discussion of Greenberg's correspondence with the Unabomber.
Gary Greenberg, journalist for Harpers, the New Yorker, Rolling Stone and others, discusses being a subject in a clinical drug trial, how depression is manipulated by advertising and Big Pharma, and the social medicalizing of experience. [Read more...]
Guest: Gary Greenberg, MD Host: Larry Kaskel, MD Dr. Larry Kaskel is joined by psychotherapist and freelance journalist Dr. Gary Greenberg who participated in a clinical trial for a new anti-depression medication. He discusses the fact that in over half the trials used to approve the six leading anti-depressants, the drugs failed to outperform the placebo. He also speaks about the discovery of a pattern of brain activity that is common to those subjects who respond to the placebo.
Guest: Gary Greenberg, MD Host: Larry Kaskel, MD Dr. Larry Kaskel is joined by psychotherapist and freelance journalist, Dr. Gary Greenberg who will discuss his fascinating experience from inside a clinical trial for a new anti-depression medication.